$MBVX MABVAX THERAPEUTICS HOLDINGS, INC. Insider Trading Week 14/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MABVAX THERAPEUTICS HOLDINGS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in MABVAX THERAPEUTICS HOLDINGS, INC. in week 14/2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 06 2017 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Sell | S | 2.15 | 867 | 1,862 | 23,645 | 24.5 K to 23.6 K (-3.54 %) |
| Apr 06 2017 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Sell | S | 2.15 | 1,800 | 3,872 | 24,512 | 26.3 K to 24.5 K (-6.84 %) |
| Apr 06 2017 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Sell | S | 2.25 | 1,000 | 2,250 | 26,312 | 27.3 K to 26.3 K (-3.66 %) |
| Apr 06 2017 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Sell | S | 2.15 | 867 | 1,862 | 34,141 | 35 K to 34.1 K (-2.48 %) |
| Apr 06 2017 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Sell | S | 2.15 | 1,800 | 3,872 | 35,008 | 36.8 K to 35 K (-4.89 %) |
| Apr 06 2017 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Sell | S | 2.25 | 1,000 | 2,250 | 36,808 | 37.8 K to 36.8 K (-2.64 %) |
| Apr 06 2017 | MBVX | MABVAX THERAPEUTIC ... | HANSEN JOHN DAVID | PRESIDENT AND CEO | Sell | S | 2.15 | 1,501 | 3,223 | 73,165 | 74.7 K to 73.2 K (-2.01 %) |
| Apr 06 2017 | MBVX | MABVAX THERAPEUTIC ... | HANSEN JOHN DAVID | PRESIDENT AND CEO | Sell | S | 2.15 | 2,450 | 5,271 | 74,666 | 77.1 K to 74.7 K (-3.18 %) |
| Apr 06 2017 | MBVX | MABVAX THERAPEUTIC ... | HANSEN JOHN DAVID | PRESIDENT AND CEO | Sell | S | 2.25 | 1,100 | 2,475 | 77,116 | 78.2 K to 77.1 K (-1.41 %) |
| Apr 04 2017 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Option Exercise | M | 0.00 | 15,045 | 0 | 15,046 | |
| Apr 04 2017 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Buy | M | 0.00 | 15,045 | 0 | 27,312 | 12.3 K to 27.3 K (+122.65 %) |
| Apr 04 2017 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Option Exercise | M | 0.00 | 21,064 | 0 | 21,063 | |
| Apr 04 2017 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Buy | M | 0.00 | 21,064 | 0 | 37,808 | 16.7 K to 37.8 K (+125.80 %) |
| Apr 04 2017 | MBVX | MABVAX THERAPEUTIC ... | HANSEN JOHN DAVID | PRESIDENT AND CEO | Option Exercise | M | 0.00 | 40,687 | 0 | 40,687 | |
| Apr 04 2017 | MBVX | MABVAX THERAPEUTIC ... | HANSEN JOHN DAVID | PRESIDENT AND CEO | Buy | M | 0.00 | 40,687 | 0 | 78,216 | 37.5 K to 78.2 K (+108.41 %) |
| Apr 04 2017 | MBVX | MABVAX THERAPEUTIC ... | HOFFMAN ROBERT | Option Exercise | M | 0.00 | 1,543 | 0 | 1,543 | ||
| Apr 04 2017 | MBVX | MABVAX THERAPEUTIC ... | HOFFMAN ROBERT | Buy | M | 0.00 | 1,543 | 0 | 4,438 | 2.9 K to 4.4 K (+53.30 %) | |
| Apr 04 2017 | MBVX | MABVAX THERAPEUTIC ... | Cohen Kenneth M | Option Exercise | M | 0.00 | 1,543 | 0 | 1,543 | ||
| Apr 04 2017 | MBVX | MABVAX THERAPEUTIC ... | Cohen Kenneth M | Buy | M | 0.00 | 1,543 | 0 | 7,557 | 6 K to 7.6 K (+25.66 %) | |
| Apr 04 2017 | MBVX | MABVAX THERAPEUTIC ... | MAIER PAUL V | Option Exercise | M | 0.00 | 1,543 | 0 | 1,543 | ||
| Apr 04 2017 | MBVX | MABVAX THERAPEUTIC ... | MAIER PAUL V | Buy | M | 0.00 | 1,543 | 0 | 3,762 | 2.2 K to 3.8 K (+69.54 %) | |
| Apr 04 2017 | MBVX | MABVAX THERAPEUTIC ... | Varvaro Thomas C | Option Exercise | M | 0.00 | 1,543 | 0 | 1,543 | ||
| Apr 04 2017 | MBVX | MABVAX THERAPEUTIC ... | Varvaro Thomas C | Buy | M | 0.00 | 1,543 | 0 | 3,086 | 1.5 K to 3.1 K (+100.00 %) | |
| Apr 04 2017 | MBVX | MABVAX THERAPEUTIC ... | Ravetch Jeffrey V. | Option Exercise | M | 0.00 | 1,543 | 0 | 1,543 | ||
| Apr 04 2017 | MBVX | MABVAX THERAPEUTIC ... | Ravetch Jeffrey V. | Buy | M | 0.00 | 1,543 | 0 | 3,086 | 1.5 K to 3.1 K (+100.00 %) |